期刊文献+

慢性阻塞性肺疾病大鼠肺组织中肺表面活性物质蛋白-C表达下降 被引量:3

Decreased expression of surfactant protein C in lung tissue of chronic obstructive pulmonary disease rats
下载PDF
导出
摘要 目的探讨肺表面活性物质蛋白-C(SP-C)在慢性阻塞性肺疾病(COPD)大鼠肺组织中的作用。方法将大鼠随机分为对照组、香烟烟雾暴露组、脂多糖组和COPD组,每组10只。测定各组大鼠的PaO_2和PaCO_2的水平;透射电镜观察肺组织的细胞微观结构;ELISA检测支气管肺泡灌洗液(BALF)和肺组织SP-C蛋白;RT-q PCR检测肺组织SP-C mRNA的表达。结果与其他组相比,COPD大鼠的PaO_2最低,而PaCO_2最高;肺泡Ⅱ型上皮细胞表面微绒毛明显减少(P<0.01);BALF和肺组织中SP-C蛋白表达下降(P<0.01);肺组织中的SP-C mRNA表达下降(P<0.01)。结论 SP-C在COPD大鼠肺组织中表达下调,这种下调可能引起肺通气和肺换气功能障碍。 Objective To study the role of surfactant protein C( SP-C) in rat lung of chronic obstructive pulmonary disease( COPD). Methods Forty healthy conventional Sprague-Dawley( SD) rats were randomly divided into four groups,normal control group( control group),smoke exposure group( smoking group),lipopolysaccharide group( LPS group),smoke exposure + Lipopolysaccharide group( COPD group). The arterial partial pressure oxygen( PaO_2) and arterial partial pressure of carbon dioxide pathological( PaCO_2) were detected. The ultrastructure of lung tissue was observed by transmission electron microscope. Enzyme-linked immuno sorbent assay( ELISA) were performed to determine protein expression of SP-C in lung and bronchoalveolar lavage fluid( BALF). RT-q PCR were performed to determine mRNA expression of SP-C in lung. Results Compared with control group,smoking group and LPS group,the PaO_2 of COPD group was obviously lower,the PaCO_2 of COPD group was obviously higher; the ultrastructure and histological analysis of lung tissues showed chronic inflammatory injury; Compared with control group,the expression of SP-C protein in was reduced,as well as SP-C mRNA expression. Conclusions The expression of SP-C in lung of rats COPD model is down-regulated. SP-C may be involved in COPD.
出处 《基础医学与临床》 CSCD 2018年第1期47-50,共4页 Basic and Clinical Medicine
基金 河南省科技厅基础与前沿技术研究计划(132300410160) 河南省科技厅科技攻关研究计划(162102310121) 新乡医学院高学历人才启动基金(505001)
关键词 慢性阻塞性肺疾病 表面活性物质蛋白-C 呼吸功能 chronic obstructive pulmonary disease surfactant protein C respiratory function
  • 相关文献

参考文献4

二级参考文献40

  • 1Pauwels RA, Buist AS, Calverley PM, et al. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBL/WHO Global initiative for Chronic Obstructive Lung Disease(GOLD) Workshop summary[ J]. Am J Respir Crit Care Med, 163 : 1256 - 1276. 被引量:1
  • 2Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med, 2002,347(26):2141-2148. 被引量:1
  • 3Gortner L, Hilgendorff A. Surfactant-associated proteins Band C: molecular biology and physiologic properties. Z Geburtshilfe Neonatal, 2004,208(3):91-97. 被引量:1
  • 4Jacot W, Bousquet J. Understanding the regulation of surfactant gene expression. Eur Respi J, 2003,22(1 ):6-7. 被引量:1
  • 5Bachurski CJ, Yang GH, Currier TA, et al. Nuclear factor I Ithyroid transcription factor 1 interactions modulate surfactant protein C transcription. Mol Cell Bioi, 2003,23(24):9014-9024. 被引量:1
  • 6Yang MC, Gu Y, Liu CC, et al. The TTF-IITAP26 complex differentially modulates surfactant protein-B (SP-B) and -C (SP-C) promoters in lung cells. Biochem Biophys Res Commun, 2006,344(2):484-490. 被引量:1
  • 7Yang MC, Weissler JC, Terada LS, et al. PLAGL2, a zinc finger protein, transactivates the surfactant protein-C promoter. Am J Respir Cell Mol Biol, 2005,32(1 ):35-43. 被引量:1
  • 8Morrison JL, Duffield JA, Muhlhausler BS, et al. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol,2010,25(4):669-677. 被引量:1
  • 9Streimish 10, Ehrenkranz RA, Allred EN, et al. Birth weight- and fetal weight-growth restriction: impact on neurodevelopment. Early Hum Dev, 2012,88(9):765-771. 被引量:1
  • 10Soudee S, VuiIlemin L, Alberti C, et al. Fetal growth restriction is worse than extreme prematurity for the developing lung. Neonatology,2014,106(4):304-310. 被引量:1

共引文献26

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部